£13.3M
Parkwalk Advisors led the financing round, which brings Congenica to a total of £23.3m raised for its Series B.
"In addition, we can now begin to penetrate international markets. The deepening of our relationship with DCHealth gives us greater insight into the needs of the China market, with the recent development of an on-premise version of our platform the most notable example."
Parkwalk Advisors + 1 other
